Beijing Hanmi Pharmaceutical, First in Chinese Pharmaceutical Industry to Receive 'ISO73001' Certification

Acquisition of International Standard Certification for Anti-Corruption Management System

At the ISO37001 certification award ceremony, Im Haeryong, General Manager of Beijing Hanmi Pharm (right in the photo), is taking a commemorative photo with Shin Bin, General Manager of SGS. Photo by Shin Bin

[Asia Economy Reporter Lee Chunhee] Beijing Hanmi Pharmaceutical announced on the 16th that it has become the first company in the Chinese pharmaceutical industry to receive the 'ISO37001' certification, the international standard for anti-corruption management systems.

At the certification ceremony held last February, Lim Haeryong, General Manager, and more than 60 team leaders and above from Beijing Hanmi Pharmaceutical, along with Shin Bin, General Manager of SGS, attended. This certification is valid for approximately three years until January 2025.

ISO37001 is an anti-corruption management system established by the International Organization for Standardization (ISO) to prevent the possibility of corruption within organizations through systematic measures. In China, SGS, recognized by the State Administration for Market Regulation, oversees the certification. Since January last year, SGS has conducted rigorous audits covering internal compliance program (CP) inspections, training, and evaluations at Beijing Hanmi Pharmaceutical.

ISO37001 stipulates that companies identify CP risks arising during business operations in advance and specify related organizational policies, handling procedures, and practical measures, enabling organizations to manage anti-corruption actions reasonably and appropriately.

To obtain ISO37001 certification, Beijing Hanmi Pharmaceutical has built a systematic system through annual company-wide CP inspections, training, and performance evaluations for over ten years. Additionally, it has fostered an ethical management environment by enhancing voluntary CP compliance and awareness among all employees.

General Manager Lim said, “Being the first in the Chinese pharmaceutical industry to receive ISO37001 certification signifies recognition of our rigorous anti-corruption system and the firm CP compliance commitment of over 1,300 employees.” He added, “We will use this certification as an opportunity for all employees to reaffirm their CP compliance awareness and firmly establish ourselves as a model company in the Chinese pharmaceutical industry.”

This content was produced with the assistance of AI translation services.